Develops non-invasive cervical cancer detection devices.
Jun 2026Revenue $650K/yrExpenses $2.63M/yr
No trend
Figures by year
When will Guided Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $650K and expenses $2.63M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $767K | $3.14M | −$2.37M |
| Dec 2024 | $7.00K | $2.12M | −$2.11M |
| Dec 2023 | $98.0K | $3.56M | −$3.46M |
| Dec 2022 | $13.0K | $3.35M | −$3.33M |
| Dec 2021 | $81.0K | $2.44M | −$2.36M |
| Dec 2020 | $102K | $1.15M | −$1.05M |
| Dec 2019 | $36.0K | $973K | −$937K |
| Dec 2018 | $57.0K | $1.60M | −$1.55M |
| Dec 2017 | $244K | $3.37M | −$3.12M |
| Dec 2016 | $0.00 | $3.82M | −$3.82M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.